BNF:

11.6

Status:

Do Not Prescribe (DNP), Grey - after consultant/specialist recommendation

Decision Date:

July 2019

Comments

GREY after consultant/specialist initiation: 2nd line prostaglandin analogue. (40micrograms/ml eye drops). Cost effective to prescribe generically. (Decision date - July 2022)

DNP: Not to be prescribed by brand - Travatan. (Decision date - August 2019)

search again